Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Waverley Pharma Inc V.WAVE

Waverley Pharma Inc. is a biopharmaceutical company engaged in the research, development, and commercialization of human therapeutics focused on oncology. Its primary focus is the PARP-1 program and secondary focus is the generic oncology injectable market in European Union, the United Kingdom (UK) and North America. It has entered into a license, manufacture, supply, marketing and distribution agreement with Reliance Life Sciences Private Limited, which has granted it an exclusive territorial license to market and sell capecitabine in the UK and Germany as well as a non-exclusive territorial license to market and sell temozolomide and erlotinib in the UK. Its generic oncology products include bortezomib and pemetrexed. Bortezomib is an injectable generic chemotherapy drug, developed for the treatment of multiple myeloma and mantle cell lymphoma. Pemetrexed is an injectable generic chemotherapy drug, developed for the treatment of non-small cell lung cancer and pleural mesothelioma.


TSXV:WAVE - Post by User

Post by NEMOMEIMPUNEon Mar 29, 2021 8:55am
206 Views
Post# 32897141

We will get news in april...

We will get news in april......but I think it will be in the later part of the month.

But it will be good!!
But not as good as next year (there 's analysis with prognose of CAD: 10 in the first quarter -22) 

I'm thankful for my foresight to buy the amount of shares I wanted, before the shares dried up during the first quarter this year. Now I can wait for the reults without fear and that is more than one can say about those who still think they are smart, waiting till the last second hopeing to scoop up shares that are not there to buy. (There is probably even those who will laugh out of joy, when they sell for pennies this summer and coming fall).
But those people will have another possibility, but not at this low shareprice.
They may find those higer levels ok, ...IF they can manage to sit tight on their shares till they spot the shareprice in first quarter of 2022.

NEMO
<< Previous
Bullboard Posts
Next >>